{"id":"administration-of-avp","safety":{"commonSideEffects":[{"rate":null,"effect":"Peripheral vasoconstriction"},{"rate":null,"effect":"Hyponatremia"},{"rate":null,"effect":"Cardiac arrhythmias"},{"rate":null,"effect":"Mesenteric ischemia"}]},"_chembl":{"chemblId":"CHEMBL1807688","moleculeType":"Protein","molecularWeight":"285.34"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"AVP (arginine vasopressin, also known as antidiuretic hormone) binds to V1 and V2 receptors on vascular smooth muscle and renal collecting ducts, causing vasoconstriction and fluid retention. This mechanism is used therapeutically to treat hypotension and maintain hemodynamic stability in critical care settings.","oneSentence":"AVP is an arginine vasopressin analog that acts as a vasopressor agent to increase blood pressure and peripheral vascular resistance.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:59:49.957Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypotension in septic shock or critical illness"},{"name":"Variceal bleeding in portal hypertension"}]},"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT05958342","phase":"PHASE2","title":"CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial","status":"RECRUITING","sponsor":"Jason Sperry","startDate":"2024-06-30","conditions":"Trauma, Hemorrhage","enrollment":1050},{"nctId":"NCT07446933","phase":"PHASE2","title":"Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2024-03-20","conditions":"Cesarean Section Complications","enrollment":30},{"nctId":"NCT07438925","phase":"","title":"Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-12-22","conditions":"Hemodialysis","enrollment":71},{"nctId":"NCT04489823","phase":"NA","title":"PARADIGM: Amplatzer Valvular Plug for PVL Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2020-12-01","conditions":"Paravalvular Aortic Regurgitation","enrollment":200},{"nctId":"NCT05824767","phase":"PHASE4","title":"Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2023-04-17","conditions":"Septic Shock, Vasodilatory Shock","enrollment":40},{"nctId":"NCT05190744","phase":"PHASE2","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-09-01","conditions":"Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus","enrollment":36},{"nctId":"NCT04897802","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-09-13","conditions":"Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism","enrollment":42},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT02118467","phase":"PHASE4","title":"Vasoactive Drugs in Intensive Care Unit","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2014-05-15","conditions":"Shock","enrollment":836},{"nctId":"NCT07328529","phase":"PHASE2","title":"Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Azevan Pharmaceuticals","startDate":"2026-03","conditions":"Aggressive Behavior in Fragile X Syndome","enrollment":80},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT06838143","phase":"","title":"Ilaris NIS in Korea","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-03-29","conditions":"Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF)","enrollment":25},{"nctId":"NCT05568160","phase":"PHASE3","title":"Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-01-02","conditions":"Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome","enrollment":840},{"nctId":"NCT07286643","phase":"NA","title":"Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-01-01","conditions":"Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock","enrollment":140},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06203847","phase":"NA","title":"The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-07-16","conditions":"Cardiac Arrest, Out-Of-Hospital Cardiac Arrest, Emergency Medical Services","enrollment":1344},{"nctId":"NCT07102615","phase":"PHASE4","title":"Intracervical Vasopressin","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Retained Products of Conception","enrollment":50},{"nctId":"NCT06217562","phase":"PHASE4","title":"Vasopressin for Septic Shock Pragmatic Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2024-02-01","conditions":"Septic Shock","enrollment":2050},{"nctId":"NCT06605300","phase":"NA","title":"The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-10-02","conditions":"Healthy","enrollment":120},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT04592744","phase":"PHASE4","title":"Angiotensin 2 for AKI After OLT","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2022-04-08","conditions":"Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury","enrollment":30},{"nctId":"NCT07052084","phase":"PHASE3","title":"Systematic Adjunction of Vasopressine in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2026-01","conditions":"Septic Shock","enrollment":120},{"nctId":"NCT06846138","phase":"NA","title":"Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study","status":"ENROLLING_BY_INVITATION","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2025-03-01","conditions":"Diabetes Mellitus Type 2","enrollment":66},{"nctId":"NCT06155812","phase":"PHASE2, PHASE3","title":"Multimodal Vasopressor Strategy in Septic Shock","status":"RECRUITING","sponsor":"University Medical Centre Maribor","startDate":"2023-12-23","conditions":"Shock, Septic","enrollment":80},{"nctId":"NCT04591990","phase":"PHASE3","title":"HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-05-27","conditions":"Postresuscitation Syndrome","enrollment":380},{"nctId":"NCT06020495","phase":"PHASE3","title":"Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-12-17","conditions":"Hyponatremia","enrollment":260},{"nctId":"NCT06593054","phase":"PHASE1","title":"To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-07-29","conditions":"Healthy","enrollment":13},{"nctId":"NCT03446456","phase":"PHASE1, PHASE2","title":"Vasopressin and Pain Perception in the Brain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2018-09-17","conditions":"Acute Pain","enrollment":40},{"nctId":"NCT05044611","phase":"PHASE4","title":"AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-11","conditions":"Bipolar Disorder","enrollment":148},{"nctId":"NCT06547892","phase":"PHASE2","title":"Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-04-10","conditions":"Critical Illness","enrollment":60},{"nctId":"NCT04501861","phase":"PHASE3","title":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-11-05","conditions":"Cardiac Disease","enrollment":153},{"nctId":"NCT05902117","phase":"NA","title":"Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS","status":"COMPLETED","sponsor":"Hôpital NOVO","startDate":"2023-06-28","conditions":"Acute Myocardial Infarction","enrollment":270},{"nctId":"NCT05293041","phase":"PHASE4","title":"Argipressin's Influence on Blood Loss During Hepatic Resection","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2022-03-27","conditions":"Colon Cancer Liver Metastasis, Inflammatory Response, Vasopressin Causing Adverse Effects in Therapeutic Use","enrollment":248},{"nctId":"NCT06853574","phase":"NA","title":"Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"General and Teaching Hospital Celje","startDate":"2025-02","conditions":"Sepsis, Septic Shock","enrollment":30},{"nctId":"NCT06789705","phase":"NA","title":"Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-27","conditions":"Central Diabetes Insipidus","enrollment":24},{"nctId":"NCT06604975","phase":"NA","title":"Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2025-03","conditions":"Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus","enrollment":155},{"nctId":"NCT06419075","phase":"PHASE4","title":"Tranexamic Acid in Vaginal Reconstructive Surgery","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2024-07-01","conditions":"Pelvic Organ Prolapse","enrollment":""},{"nctId":"NCT06772584","phase":"NA","title":"Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-01-01","conditions":"Enuresis, Nocturnal","enrollment":90},{"nctId":"NCT01733134","phase":"PHASE3","title":"Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)","status":"WITHDRAWN","sponsor":"Maisel, Alan, M.D.","startDate":"","conditions":"Acute Heart Failure","enrollment":""},{"nctId":"NCT06471231","phase":"PHASE4","title":"Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2024-05-15","conditions":"Septic Shock, Renal Function Replacement","enrollment":264},{"nctId":"NCT06376318","phase":"","title":"Shock and Acute Conditions OutcOmes Platform","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saint-Louis Hospital, Paris, France","startDate":"2024-01-01","conditions":"Circulatory Shock, Sepsis, Cardiogenic Shock","enrollment":1000},{"nctId":"NCT06329063","phase":"NA","title":"Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06329037","phase":"NA","title":"The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT04902235","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-07-06","conditions":"Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism","enrollment":52},{"nctId":"NCT05193370","phase":"PHASE4","title":"Angiotensin II vs. Vasopressin in Septic Shock","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-01-03","conditions":"Septic Shock","enrollment":""},{"nctId":"NCT06302998","phase":"PHASE2","title":"Dexmedetomidine and Vasopressin in Septic Shock","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2024-06","conditions":"Sepsis, Septic Shock","enrollment":260},{"nctId":"NCT06265259","phase":"PHASE4","title":"Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2023-12-15","conditions":"Circulatory Shock","enrollment":145},{"nctId":"NCT06185361","phase":"NA","title":"Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.","status":"UNKNOWN","sponsor":"Fayoum University Hospital","startDate":"2022-12-01","conditions":"Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal","enrollment":60},{"nctId":"NCT04890470","phase":"NA","title":"Effects of Oxytocin and Vasopressin on Moral Decision Making","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2021-03-02","conditions":"Healthy","enrollment":180},{"nctId":"NCT03737110","phase":"PHASE3","title":"Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis","status":"COMPLETED","sponsor":"Kiniksa Pharmaceuticals (UK), Ltd.","startDate":"2019-01-07","conditions":"Recurrent Pericarditis","enrollment":86},{"nctId":"NCT05617664","phase":"NA","title":"Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Benha University","startDate":"2022-11-23","conditions":"Nocturnal Enuresis","enrollment":150},{"nctId":"NCT03389412","phase":"PHASE4","title":"The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-10-01","conditions":"Enuresis, Nocturnal","enrollment":324},{"nctId":"NCT05945420","phase":"PHASE4","title":"Adding Desmopressin to Tamsulosin for Treatment of BPH","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-07-20","conditions":"Nocturnal Polyurea in Patients With BPH","enrollment":160},{"nctId":"NCT04939753","phase":"","title":"Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2021-05-26","conditions":"Nephrogenic Diabetes Insipidus","enrollment":1000},{"nctId":"NCT03636451","phase":"PHASE3","title":"Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-10-29","conditions":"Abortion, Spontaneous, Abortion in First Trimester, Pain Uterus","enrollment":114},{"nctId":"NCT04064346","phase":"PHASE3","title":"Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease","status":"TERMINATED","sponsor":"Palladio Biosciences","startDate":"2021-10-28","conditions":"Autosomal Dominant Polycystic Kidney, ADPKD","enrollment":12},{"nctId":"NCT04396041","phase":"","title":"Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-09-01","conditions":"Pulmonary Arteriovenous Malformation","enrollment":223},{"nctId":"NCT01439997","phase":"PHASE4","title":"Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2012-03-26","conditions":"Nocturia","enrollment":5},{"nctId":"NCT05628558","phase":"","title":"Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A","status":"UNKNOWN","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2020-07-01","conditions":"Hemophilia A, Mild, Desmopressin, Factor VIII","enrollment":800},{"nctId":"NCT05439460","phase":"PHASE4","title":"Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-01","conditions":"Pulmonary Arterial Hypertension","enrollment":15},{"nctId":"NCT05297630","phase":"","title":"Comparative Evaluation of the Evolution of Emerging Biological Markers in Patients Hospitalized for Acute Heart Failure According to Conventional Management or Therapeutic Adjustment Via Daily Ultrasound.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2022-02-15","conditions":"Heart Failure","enrollment":169},{"nctId":"NCT04089072","phase":"PHASE2","title":"Methylene Blue as a Third-line Vasopressor in Septic Shock","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2019-12-01","conditions":"Septic Shock","enrollment":250},{"nctId":"NCT02476409","phase":"PHASE4","title":"Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-07","conditions":"Congestive Heart Failure","enrollment":40},{"nctId":"NCT04648137","phase":"NA","title":"Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-02-05","conditions":"Diabetes Insipidus","enrollment":30},{"nctId":"NCT05307042","phase":"","title":"Decline in Renal Concentration Ability in Lithium Treated Patients","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-05","conditions":"Lithium Toxicities, Bipolar Disorder, Concentration Ability Impaired","enrollment":51},{"nctId":"NCT03201419","phase":"PHASE2","title":"A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-27","conditions":"Nocturia","enrollment":302},{"nctId":"NCT05139849","phase":"PHASE3","title":"VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial","status":"RECRUITING","sponsor":"Tiohundra AB","startDate":"2021-11-17","conditions":"Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial","enrollment":1276},{"nctId":"NCT02621736","phase":"","title":"Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-01-01","conditions":"Nocturnal Enuresis","enrollment":28},{"nctId":"NCT02733614","phase":"PHASE2","title":"Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD","status":"TERMINATED","sponsor":"Azevan Pharmaceuticals","startDate":"2016-12","conditions":"PTSD","enrollment":33},{"nctId":"NCT04991259","phase":"NA","title":"To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-08-10","conditions":"Acute Liver Failure","enrollment":60},{"nctId":"NCT04715737","phase":"NA","title":"Differential Effects of Vasopressin and Oxytocin on Attention Control","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2017-12-19","conditions":"Healthy","enrollment":160},{"nctId":"NCT04493554","phase":"NA","title":"The Effects of Vasopressin on Attention Control","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-07-28","conditions":"Healthy","enrollment":89},{"nctId":"NCT03917758","phase":"NA","title":"Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors","status":"UNKNOWN","sponsor":"University of Turin, Italy","startDate":"2018-10-10","conditions":"Diabetes Mellitus, Type 2, Arterial Hypertension, Body Weight Changes","enrollment":30},{"nctId":"NCT02967653","phase":"PHASE2","title":"Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus","status":"COMPLETED","sponsor":"Lady Davis Institute","startDate":"2017-07-13","conditions":"Lithium Use, Nephrogenic Diabetes Insipidus","enrollment":60},{"nctId":"NCT04545931","phase":"PHASE4","title":"Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"Primary Monosymptomatic Nocturnal Enuresis","enrollment":80},{"nctId":"NCT02959411","phase":"PHASE4","title":"Tolvaptan for Advanced or Refractory Heart Failure","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2016-10","conditions":"Heart Failure, Hyponatremia","enrollment":9},{"nctId":"NCT03088345","phase":"PHASE2, PHASE3","title":"Early Use of Vasopressin in Post-Fontan Management","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2017-03-06","conditions":"Circulatory Perfusion Disorder, Congenital Heart Disease, Single-ventricle","enrollment":20},{"nctId":"NCT04190004","phase":"NA","title":"Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia","status":"COMPLETED","sponsor":"National Institute of Mental Health and Neuro Sciences, India","startDate":"2018-01-01","conditions":"Schizophrenia","enrollment":30},{"nctId":"NCT02718079","phase":"NA","title":"High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-12-30","conditions":"Acute Liver Failure","enrollment":40},{"nctId":"NCT02090829","phase":"PHASE2","title":"Intranasal Oxytocin and Learning in Autism","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2014-03","conditions":"Autism Spectrum Disorders","enrollment":""},{"nctId":"NCT02994316","phase":"NA","title":"Plasma Copeptin Levels in Children With Diabetic Ketoacidosis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-10-03","conditions":"Diabetic Ketoacidosis Children","enrollment":58},{"nctId":"NCT04119206","phase":"","title":"Tolvaptan Versus Fluid Restriction in SIADH","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2009-01-01","conditions":"Hyponatremia, Syndrome of Inappropriate ADH (SIADH) Secretion, Pituitary","enrollment":334},{"nctId":"NCT04113005","phase":"EARLY_PHASE1","title":"Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-10-01","conditions":"Castrate Resistance Prostate Cancer","enrollment":10},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT02905682","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":190},{"nctId":"NCT02904759","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":342},{"nctId":"NCT00624650","phase":"PHASE2","title":"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-02","conditions":"Acute Lung Injury","enrollment":33},{"nctId":"NCT03923140","phase":"PHASE2","title":"A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-05-23","conditions":"Cryopyrin-Associated Periodic Syndromes","enrollment":71},{"nctId":"NCT01962870","phase":"PHASE2","title":"The Role of Vasopressin in the Social Deficits of Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-12","conditions":"Autism Spectrum Disorders","enrollment":68},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435},{"nctId":"NCT01318278","phase":"NA","title":"Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-03","conditions":"Hypotension","enrollment":70},{"nctId":"NCT01036841","phase":"PHASE4","title":"Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2009-12","conditions":"Enuresis, Polyuria","enrollment":24},{"nctId":"NCT02584231","phase":"PHASE4","title":"Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population","status":"COMPLETED","sponsor":"University Ghent","startDate":"2015-09-09","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":25},{"nctId":"NCT03590873","phase":"NA","title":"The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients","status":"UNKNOWN","sponsor":"Hangang Sacred Heart Hospital","startDate":"2018-07-25","conditions":"Burn Surgery","enrollment":158}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Administration of AVP","genericName":"Administration of AVP","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AVP is an arginine vasopressin analog that acts as a vasopressor agent to increase blood pressure and peripheral vascular resistance. Used for Hypotension in septic shock or critical illness, Variceal bleeding in portal hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}